Zydus Cadila will start second phase of clinical trials of its Covid-19 vaccine candidate, ZyCoV-D, the company said. "ZyCoV-D was found to be safe and well tolerated in the phase I clinical trial.
The company will now commence phase II clinical trials from the 6th of August, 2020.The United States government will pay Johnson & Johnson over $1 billion for 100 million doses of its potential coronavirus vaccine, as it stocks up on vaccine and drugs in an attempt to tame the pandemic.Click here to read the Mint ePaperLivemint.com is now on Telegram.